30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Henderson Jeffrey William

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 26% 68% 82%
Transactions
7 14% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Henderson Jeffrey William's trades of Halozyme Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-28 2025-04-28
PlS Planned sale
76,455 +16.0%
393.23
US$2,649,355 		76,455 +16.0% 393.23 US$2,649,355
2025-04-28 2025-04-28
PlS Planned sale
21,303 -7.8%
212.31
US$2,569,661 		21,303 -7.8% 212.31 US$2,569,661
2025-04-01 2025-04-01
PlS Planned sale
5,199 +49.0%
317.41
US$4,981,743 		5,199 +49.0% 317.41 US$4,981,743
2025-03-03 2025-03-03
PlS Planned sale
3,205 -8.7%
59.12
US$189,467 		3,205 -8.7% 59.12 US$189,467
2025-03-03 2025-03-03
PlS Planned sale
1,795 -4.6%
57.93
US$103,992 		1,795 -4.6% 57.93 US$103,992
2025-02-10 2025-02-10
B Purchase
1,500 +23.0%
233.62
US$350,430 		1,500 +23.0% 233.62 US$350,430
2025-02-04 2025-02-03
PlS Planned sale
3,900 -9.2%
56.41
US$219,980 		3,900 -9.2% 56.41 US$219,980
2025-02-04 2025-02-03
PlS Planned sale
1,100 -2.5%
55.94
US$61,537 		1,100 -2.5% 55.94 US$61,537
2025-02-03 2025-02-03
PrS Proposed sale
15,000
56.64
US$849,600 		15,000 56.64 US$849,600
2025-01-07 2025-01-06
PlS Planned sale
10,000 -18.7%
50.01
US$500,060 		10,000 -18.7% 50.01 US$500,060
2025-01-06 2025-01-06
PrS Proposed sale
10,000
47.74
US$477,400 		10,000 47.74 US$477,400
2023-09-06 2023-09-01
US FibroGen Inc (FGEN)
PlS Planned sale
2,000 -6.5%
1.03
US$2,060 		2,000 -6.5% 1.03 US$2,060
2023-09-01 2023-09-01
US FibroGen Inc (FGEN)
PrS Proposed sale
2,000
1.06
US$2,120 		2,000 1.06 US$2,120
2023-08-08 2023-08-04
US FibroGen Inc (FGEN)
PlS Planned sale
2,000 -6.1%
1.91
US$3,820 		2,000 -6.1% 1.91 US$3,820
2023-08-04 2023-08-04
US FibroGen Inc (FGEN)
PrS Proposed sale
2,000
1.91
US$3,820 		2,000 1.91 US$3,820
2023-07-13 2023-07-11
US FibroGen Inc (FGEN)
PlS Planned sale
2,000 -5.7%
2.69
US$5,380 		2,000 -5.7% 2.69 US$5,380
2023-07-11 2023-07-11
US FibroGen Inc (FGEN)
PrS Proposed sale
2,000
2.73
US$5,460 		2,000 2.73 US$5,460
2023-06-09 2023-06-08
US FibroGen Inc (FGEN)
PlS Planned sale
4,994 -12.5%
17.69
US$88,344 		4,994 -12.5% 17.69 US$88,344
2023-06-09 2023-06-08
US FibroGen Inc (FGEN)
PlS Planned sale
2,006 -4.8%
16.87
US$33,841 		2,006 -4.8% 16.87 US$33,841
2023-06-08 2023-06-08
US FibroGen Inc (FGEN)
PrS Proposed sale
7,000
17.78
US$124,460 		7,000 17.78 US$124,460
2023-03-01 2023-03-01
S Sale
10,000 -20.4%
47.71
US$477,100 		10,000 -20.4% 47.71 US$477,100
2023-03-01 2023-02-28
S Sale
10,000 -16.9%
48.51
US$485,100 		10,000 -16.9% 48.51 US$485,100
2023-02-24 2023-02-23
US Qualcomm Inc (QCOM)
S Sale
2,500 -54.3%
124.19
US$310,468 		2,500 -54.3% 124.19 US$310,468
2023-02-24 2023-02-22
US Qualcomm Inc (QCOM)
S Sale
2,500 -35.2%
124.05
US$310,132 		2,500 -35.2% 124.05 US$310,132
2020-11-25 2020-11-25
S Sale
24,498 -34.0%
40.08
US$981,757 		24,498 -34.0% 40.08 US$981,757
2020-11-12 2020-11-10
US Qualcomm Inc (QCOM)
S Sale
6,000 -83.2%
141.10
US$846,602 		6,000 -83.2% 141.10 US$846,602